Related Experiment Videos
Pathogenesis of steatohepatitis.
1Centre for Liver Research, Floor 4 William Leech Building, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Best Practice & Research. Clinical Gastroenterology
|October 31, 2002
Summary
Non-alcoholic steatohepatitis (NASH) progresses to liver fibrosis and cirrhosis. This review revises the two-hit pathogenesis model, emphasizing insulin resistance and free fatty acids for new treatment strategies.
Area of Science:
- Hepatology
- Metabolic Syndrome
- Pathogenesis Research
Background:
- Non-alcoholic steatohepatitis (NASH) is a significant health concern due to its potential progression to liver fibrosis and cirrhosis.
- The established 'two-hit' model suggests steatosis (fatty liver) sensitizes the liver to injury, but requires updates.
- Recent research highlights the critical roles of insulin resistance and obesity in NASH development.
Purpose of the Study:
- To critically review the 'two-hit' model of NASH pathogenesis.
- To explore recent advancements in understanding the link between obesity, insulin resistance, and liver injury.
- To propose a modified model emphasizing the role of free fatty acids in NASH.
Main Methods:
- Literature review of studies published in the 4 years following the proposal of the 'two-hit' model.
- Analysis of cellular mechanisms connecting obesity and insulin resistance.
- Synthesis of findings to propose a modified pathogenesis model.
Main Results:
- The review examines the 'two-hit' model in light of new evidence.
- Insulin resistance and its cellular mechanisms are analyzed in detail.
- The importance of free fatty acids in NASH pathogenesis is highlighted.
Conclusions:
- The existing 'two-hit' model requires modification to fully incorporate current understanding.
- A revised model emphasizing free fatty acids offers a better framework for NASH research.
- This updated model can guide the rational development of targeted NASH treatments.